Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02329977
Other study ID # 20130508-2
Secondary ID
Status Completed
Phase N/A
First received December 20, 2014
Last updated December 1, 2015
Start date June 2013
Est. completion date January 2014

Study information

Verified date December 2015
Source Fourth Military Medical University
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Observational

Clinical Trial Summary

ERCP is the primary choice for removal of common bile duct stone (CBDS) currently. However, 4-24% patients underwent recurrence after successful clearance of CBDS. Stone re-formation due to chronic inflammation of biliary duct is generally considered an important cause of CBDS recurrence, which is associated with duodenal-biliary reflux (DBR) after sphincterotomy. Although it was believed that DBR was the important cause of CBDS recurrence, the direct evidence was still lacking. Here we conducted a case control study to investigate the DBR rate in patients with recurrent CBDS after ERCP.


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date January 2014
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with common bile duct stone underwent successful stone removal by ERCP in Xijing Hospital of Digestive Diseases.

Exclusion Criteria:

- Gallbladder stones or hepatolithiasis;

- Stenosis of biliary duct;

- Incomplete common bile duct stone removal by ERCP;

- Common bile duct stent;

- Unable to provide informed consent.

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Intervention

Other:
standard barium meal examination
All eligible patients received standard barium meal examination, MRCP and enhanced abdominal CT.

Locations

Country Name City State
China Xijing Hospital of Digestive Diseases Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Fourth Military Medical University

Country where clinical trial is conducted

China, 

References & Publications (6)

Ando T, Tsuyuguchi T, Okugawa T, Saito M, Ishihara T, Yamaguchi T, Saisho H. Risk factors for recurrent bile duct stones after endoscopic papillotomy. Gut. 2003 Jan;52(1):116-21. — View Citation

Cheon YK, Lehman GA. Identification of risk factors for stone recurrence after endoscopic treatment of bile duct stones. Eur J Gastroenterol Hepatol. 2006 May;18(5):461-4. Review. — View Citation

Ishiguro J. Biliary bacteria as an indicator of the risk of recurrence of choledocholithiasis after endoscopic sphincterotomy. Diagn Ther Endosc. 1998;5(1):9-17. doi: 10.1155/DTE.5.9. — View Citation

Keizman D, Ish Shalom M, Konikoff FM. Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients. Gastrointest Endosc. 2006 Jul;64(1):60-5. — View Citation

Kim DI, Kim MH, Lee SK, Seo DW, Choi WB, Lee SS, Park HJ, Joo YH, Yoo KS, Kim HJ, Min YI. Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy. Gastrointest Endosc. 2001 Jul;54(1):42-8. Erratum in: Gastrointest Endosc 2002 Jan;55(1):144. Chol WB [corrected to Choi WB]. — View Citation

Misra SP, Dwivedi M. Reflux of duodenal contents and cholangitis in patients undergoing self-expanding metal stent placement. Gastrointest Endosc. 2009 Aug;70(2):317-21. doi: 10.1016/j.gie.2008.12.054. Epub 2009 Jun 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Duodenal-biliary reflux rate The proportion of patients with barium reflux into bile duct during the standard barium meal examination. up to 6 months Yes
Secondary Distal common bile duct angle MRCP revealed the first angulation from the ampullary orifice along the course of the common bile duct stone. up to 6 months No
Secondary Maximal CBD diameter Maximal CBD diameter was determined by MRCP. up to 6 months No
Secondary Peripapillary diverticulum Peripapillary diverticulum was defined endoscopically as the presence of a diverticulum within a 2-cm radius from the papilla and was divided into 2 types in terms of the relation between the papilla and diverticulum: type A, papilla located on the inner rim of the diverticulum or papilla located deep within the diverticulum; and type B, papilla located outside the diverticulum. up to 6 months No
Secondary Pneumobilia Pneumobilia were determined by CT up to 6 months No
See also
  Status Clinical Trial Phase
Completed NCT01190332 - Conventional Versus Rendezvous Technique of Intraoperative Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT02703077 - Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla Phase 4
Recruiting NCT01425177 - Effect of Saline Irrigation to DEcrease Rate Of Residual Common Bile Duct Stones Phase 3
Completed NCT01189734 - Comparison Between Laparoscopic Common Bile Duct Exploration and Intraoperative ERCP for Management of Common Bile Duct Stones N/A